Zobrazeno 1 - 10
of 29
pro vyhledávání: '"V. R. Zurawski"'
Autor:
H J, Gould, G A, Mackay, S N, Karagiannis, C M, O'Toole, P J, Marsh, B E, Daniel, L R, Coney, V R, Zurawski, M, Joseph, M, Capron, M, Gilbert, G F, Murphy, R, Korngold
Publikováno v:
European journal of immunology. 29(11)
Allergic reactions are mediated by IgE antibodies bound to high-affinity receptors on mast cells in peripheral tissues and are characterized by their immediacy and hypersensitivity. These properties could also be advantageous in immunotherapy against
Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis
Publikováno v:
Cancer research. 52(23)
In the past year, gp38, a glycosyl-phosphatidylinositol linked membrane protein that is overexpressed in some malignant tissues, has been shown to be the folate receptor. Using immunohistochemical techniques with the monoclonal antibody MOv19 against
Publikováno v:
Obstetrics and gynecology. 80(1)
Detection of ovarian cancer at an early stage should reduce the mortality associated with this disease. Through the Stockholm Population Registry, 5550 apparently healthy women were enrolled in a study designed in part to define the use of the CA 125
Publikováno v:
Cancer research. 52(12)
In some epithelial cells studied in vitro a membrane-bound folate receptor initiates the process for cell accumulation of 5-methyltetrahydrofolic acid. This receptor was found to be GP38, an overexpressed, glycosyl-phosphatidylinositol anchored glyco
Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein
Autor:
L R, Coney, A, Tomassetti, L, Carayannopoulos, V, Frasca, B A, Kamen, M I, Colnaghi, V R, Zurawski
Publikováno v:
Cancer research. 51(22)
Monoclonal antibodies MOv18 and MOv19, raised against a membrane preparation of an ovarian carcinoma surgical specimen, react with a surface antigen present on the majority of nonmucinous ovarian malignant tumors tested but not with normal adult tiss
Autor:
Y H, Yu, D M, Schlossman, C L, Harrison, A, Rhinehardt-Clark, J T, Soper, T L, Klug, V R, Zurawski, R C, Bast
Publikováno v:
Cancer research. 51(2)
CA 125 has been extensively evaluated as a serum marker for monitoring patients with epithelial ovarian carcinoma. Recently, consideration has been given to the use of CA 125 as one component in a strategy for early detection of this disease. A numbe
Autor:
Robert C. Bast, N. Einhorn, R. C. Knapp, V. R. Zurawski, Kerstin Sjövall, R.E. Scully, K.P. Hall
Publikováno v:
Maturitas. 16:88
Autor:
Robert J. Linhardt, C. W. Abell, R. M. Denney, B. W. Altrock, R. Auerbach, S. D. Bernal, R. E. Canfield, P. H. Ehrlich, W. R. Moyle, T. S. Chan, T. W. Chang, N. T. Chang, J. A. Cidlowski, M. D. Viceps, R. J. Cote, D. M. Morrissey, A. N. Houghton, E. J. Beattie, H. F. Oettgen, L. J. Old, C. M. Croce, R. S. Cubicciotti, A. E. Karu, R. M. Krauss, J. S. Cullor, A. Deutsch, H. Brandwein, H. Platt, D. M. Hunter, A. Dubitsky, S. M. Durham, F. A. Dolbeare, J. W. Gray, G. R. Dreesman, C. E. Kendall, J. C. Egrie, A. R. Frackelton, H. N. Eisen, A. H. Ross, S. Gay, G. Geirnaert, J. E. Geltosky, E. H. Goldberg, E. Goldwasser, C. Kavinsky, T. L. Weiss, H. G. Gratzner, B. Hampar, M. Zweig, S. D. Showalter, H. H. Handley, M. C. Glassy, Y. Hagiwara, H. Hagiwara, C. M. Huang, S. N. Cohen, J. V. Hughes, E. M. Scolnick, J. E. Tomassini, R. Jefferis, J. Steensgaard, H. S. Kaplan, N. N. H. Teng, K. S. Earn, R. F. Calvo, L. Kass, J. R. Kettman, M. V. Norgard, M. B. Khazaeli, W. H. Beierwaltes, B. G. England, P. C. Kung, G. Goldstein, L. Lanier, J. Phillips, N. L. Warner, J. W. Larrick, A. R. Raubitschek, K. E. Truitt, H. Lazarus, J. F. Schwaber, J. Lewicki, C. Lewis, J. V. Olander, W. R. Tolbert, E. L. Milford, C. B. Carpenter, J. M. Paradysz, D. F. Mosher, J. L. Mulshine, J. D. Minna, K. A. Murray, D. M. Neville, R. J. Youle, M. Nicolson, I. Pastan, M. C. Willingham, D. J. Fitzgerald, A. Pucci, A. M. Smithyman, M. B. Slade, P. W. French, G. Wijffels, C. S. Pukel, K. O. Lloyd, L. R. Travassos, W. G. Dippold, R. P. Reckel, J. L. Harris, R. Wellerson, S. M. Shaw, P. M. Kaplan, E. L. Reinherz, S. F. Schlossman, S. C. Mener, J. Sakamoto, C. C. Cordon, E. Friedman, C. L. Finstad, W. E. Enker, M. R. Melamed, J. F. Oettgen, P. J. Scannon, L. E. Spitler, H. M. Lee, R. T. Kawahata, R. P. Mischak, J. Schlom, D. Colcher, M. Nuti, P. H. Hand, F. Austin, G. D. Shockman, D. E. Jackson, W. Wong, Z. Steplewski, H. Koprowski, M. Herlyn, M. Strand, I. S. Trowbridge, D. L. Urdal, C. J. March, S. K. Dower, J. R. Wands, V. R. Zurawski, C. A. White, R. Dulbecco, W. R. Allen, E. C. Arnold, M. Flasher, H. H. Freedman, T. D. Heath, P. Shek, D. Papahadjopoulos, M. Ikeda, S. Sakamoto, K. Suzuki, M. Kuboyama, Y. Harada, A. Kawashiri, E. Takahashi, H. S. Lee, S. Margel, R. C. Nowinski, A. S. Hoffman, J. W. Peterson, K. B. Platt, D. E. Reed, F. X. Real, M. J. Mattes, P. O. Livingston, A. Rembaum, R. C. K. Yen, R. Rosenstein, B. Schneider
Publikováno v:
Applied Biochemistry and Biotechnology. 15:53-80
Antibodies in both their free and immobilized state have been the object of considerable industrial and academic interest. A variety of methods are used for preparing and immobilizing antibodies. Applications for monoclonal antibodies include the pre
Publikováno v:
Clinical Chemistry. 31:191-195
A solid-phase, two-site monoclonal antibody radioimmunoassay for carcinoembryonic antigen in serum or plasma has been developed. Two monoclonal antibodies are used: 3d6, which is immobilized on polystyrene beads, reacts with high-molecular-mass CEA;
Autor:
Robert J. Linhardt, C. P. Bieber, F. D. Howard, J. A. Cidlowski, M. D. Viceps, J. S. Cullor, G. S. David, H. E. Greene, P. K. Donahoe, G. P. Budzik, H. M. Mudgett, J. M. Emery, D. M. Lam, M. Flashner, O. A. Gansow, M. Strand, M. I. Greene, B. N. Fields, B. Hamper, M. Zweig, H. Rabin, C. J. Heilman, R. F. Hopkins, R. H. Neubauer, E. J. Hansen, J. R. Kettman, S. M. Robertson, H. Koprowski, Z. Steplewski, M. Herlyn, M. E. Lostrom, C. Milstein, B. W. Wright, F. Murad, J. A. Lewicki, D. M. Neville, R. J. Youle, R. S. Nussenzweig, G. N. Godson, V. Nussenzweig, P. S. Paul, R. A. Van-Deusen, C. L. Reading, E. L. Reinherz, S. F. Schlossman, G. C. B. A. Ricott, W. P. Zeijlemaker, I. Royston, H. Handley, J. E. Seegmiller, L. F. Thompson, P. L. Sadowski, P. A. Sharp, C. L. Cepko, P. Changelian, W. L. Smith, D. L. DeWitt, T. A. Springer, M. Strande, I. S. Trowbridge, J. R. Wands, V. R. Zurawski, R. C. Aalberse, G. Colman, R. R. B. Russell, W. F. Feller, J. A. Kantor, J. G. Chirikjian, T. M. Philips, H. H. Freedman, K. E. Hechemy, M. Ikeda, T. Tomizawa, G. Kleinhammer, G. Deutsch, H. F. Linke, F. Stahler, W. Gruber, K. Kondo, S. Iwasa, I. Yoshida, A. R. Neurath, K. B. Platt, D. E. Reed, R. G. Runge, I. Shimizu, Y. Ohmoto, K. Imagawa, F. C. Szoka, J. Van-der-Merwe-Kirsten, A. Polson
Publikováno v:
Applied Biochemistry and Biotechnology. 11:153-167
Antibodies in both their free and immobilized state have been the object of considerable industrial and academic interest. A variety of methods are used for preparing and immobilizing antibodies. Applications for monoclonal antibodies include the pre